SCHEMBL6679316

SCHEMBL6679316

Cc1ccc2[nH]c3nc(=O)n(C)c(=O)c-3nc2c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CBFB Q13951 1/20 0.44
▸ ADAMTS5 Q9UNA0 1/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.38
▸ HSF1 Q00613 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ PDE3B Q13370 2/20 0.36
▸ PDE3A Q14432 2/20 0.36
▸ KDM4C Q9H3R0 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ POLB P06746 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ GALK1 P51570 3/20 0.36
▸ BLM P54132 3/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.36
▸ KDM4A O75164 2/20 0.36
▸ ABL1 P00519 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ RIN1 Q13671 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466847 0.83 MGAM (0.47) CBFB
SCHEMBL353026 0.66 CBFB (0.51) CBFBADAMTS5EGLN1NPC1RAB9A
SCHEMBL6373229 0.65 CBFB (0.63) CBFBNPC1RAB9ARPS6KA3
SCHEMBL25722407 0.65 RPS6KA3 (0.58) CBFBNPC1RAB9AMAPTNPSR1
SCHEMBL6368220 0.64 CBFB (0.54) CBFBADAMTS5EGLN1CHEK1HRH4
SCHEMBL5951797 0.64 FGFR1 (0.58) CBFBCHEK1ABL1KDM4EALDH1A1
SCHEMBL9144161 0.63 CBFB (0.49) CBFBADAMTS5EGLN1CHEK1PDE3B
SCHEMBL2541920 0.63 CBFB (0.49) CBFBADAMTS5EGLN1MAPTBLM
SCHEMBL4386791 0.63 CBFB (0.49) CBFBADAMTS5EGLN1CHEK1PDE3B
SCHEMBL1192237 0.63 NPC1 (0.50) CBFBADAMTS5EGLN1CHEK1PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103479-A Organic solid up-conversion material 出光兴产株式会社 2024-05-28 — — CN disclosed
EP-3630283-A1 X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS Immunolight, LLC (US) 2020-04-08 — — EP disclosed
WO-2018222798-A1 X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS IMMUNOLIGHT, LLC (US) 2018-12-06 — — WO disclosed
EP-3183037-A1 NON-INVASIVE SYSTEMS AND METHODS FOR SELECTIVE ACTIVATION OF PHOTOREACTIVE RESPONSES Immunolight, Llc. (US) 2017-06-28 — — EP disclosed
WO-2016028680-A9 NON-INVASIVE SYSTEMS AND METHODS FOR SELECTIVE ACTIVATION OF PHOTOREACTIVE RESPONSES IMMUNOLIGHT, LLC. (US) 2016-11-10 — — WO disclosed
WO-2016028680-A1 NON-INVASIVE SYSTEMS AND METHODS FOR SELECTIVE ACTIVATION OF PHOTOREACTIVE RESPONSES IMMUNOLIGHT, LLC. (US) 2016-02-25 — — WO disclosed
EP-1471940-A2 INACTIVATION OF WEST NILE VIRUS AND PLASMODIUM FALCIPARUM USING ALLOXAZINE-DERIVATING PHOTOSENSITISERS Gambro, Inc. (US) 2004-11-03 — — EP disclosed
WO-2003063902-A2 INACTIVATION OF WEST NILE VIRUS AND PLASMODIUM FALCIPARUM USING ALLOXAZINE-DERIVATING PHOTOSENSITIZERS GAMBRO, INC. (US) 2003-08-07 — — WO disclosed
Send feedback